• Radiation Oncology Journal
• /
• 제32권4호
• /
• pp.256-261
• /
• 2014

Purpose: We performed invasive thermometry to verify the elevation of local temperature in the liver during hyperthermia. Materials and Methods: Three 40-kg pigs were used for the experiments. Under general anesthesia with ultrasonography guidance, two glass fiber-optic sensors were placed in the liver, and one was placed in the peritoneal cavity in front of the liver. Another sensor was placed on the skin surface to assess superficial cooling. Six sessions of hyperthermia were delivered using the Celsius TCS electro-hyperthermia system. The energy delivered was increased from 240 kJ to 507 kJ during the 60-minute sessions. The inter-session cooling periods were at least 30 minutes. The temperature was recorded every 5 minutes by the four sensors during hyperthermia, and the increased temperatures recorded during the consecutive sessions were analyzed. Results: As the animals were anesthetized, the baseline temperature at the start of each session decreased by $1.3^{\circ}C$ to $2.8^{\circ}C$ (median, $2.1^{\circ}C$). The mean increases in temperature measured by the intrahepatic sensors were $2.42^{\circ}C$ (95% confidence interval [CI], 1.70-3.13) and $2.67^{\circ}C$ (95% CI, 2.05-3.28) during the fifth and sixth sessions, respectively. The corresponding values for the intraperitoneal sensor were $2.10^{\circ}C$ (95% CI, 0.71-3.49) and $2.87^{\circ}C$ (1.13-4.43), respectively. Conversely, the skin temperature was not increased but rather decreased according to application of the cooling system. Conclusion: We observed mean $2.67^{\circ}C$ and $2.87^{\circ}C$ increases in temperature at the liver and peritoneal cavity, respectively, during hyperthermia. In vivo real-time thermometry is useful for directly measuring internal temperature during hyperthermia.

• The Korean Journal of Pain
• /
• 제12권1호
• /
• pp.36-42
• /
• 1999

Background: The current maximal recommended doses of lidocaine are 7 mg/kg with $5\;{\mu}g/ml$ of epinephrine. But in clinical practice, sometimes more doses of lidocaine are required to produce adequate regional anesthesia. Method: Twenty-two healthy women patients were divided into two groups and pretreated with valium 5 mg p.o., morphine 5 mg i.m., and midazolam 2 mg i.v. before operation. Of these, 7 mg/kg of 2% lidocaine with $5\;{\mu}g/ml$ of epinephrine were given to 11 patients epidurally. Initial 3 ml of epinephrine mixed lidocaine was given as a test dose and remaining doses were given 5 ml/30 sec with 3 min intervals. Radial arterial blood were drawn at 5, 10, 15, 20, 30, 45, 60, 90, 120 min to measure plasma lidocaine concentrations. After confirming all of the peak plasma concentrations of 7 mg/kg lidocaine were absolutely under $5\;{\mu}g/ml$, the other 11 patients were given 10 mg/kg of 2% lidocaine with $5\;{\mu}g/ml$ of epinephrine epidurally and blood samplings were taken according to the same method of 7 mg/kg group. The peak plasma concentration ($C_{max}$), time to reach to $C_{max}$ ($T_{max}$), time to reach to $T_4$, maximal sensory block level, systemic toxicity, and vital sign changes were investigated. Result: $C_{max}$ was significantly higher in 10 mg/kg group ($5.1{\pm}1.3\;{\mu}g/ml$) than 7 mg/kg group($3.3{\pm}0.5\;{\mu}g/ml$), but $T_{max}$ ($10.5{\pm}2.7$ min vs $10.9{\pm}3.1$ min) was not different. Time to reach $T_4$ was significantly shorter in 10 mg/kg group ($9.5{\pm}2.7$ min) than 7 mg/kg group ($12.7{\pm}3.2$ min) but maximal sensory block level ($T_{3.7{\pm}0.7}$ vs $T_{2.7{\pm}1.0}$) was not different. In four patients of 10 mg/kg group, peak plasma concentrations exceeded $5\;{\mu}g/ml$, but no systemic toxicities appeared. No significant vital sign changes were observed. Conclusion: The current maximal recommended doses of lidocaine, merely based on body weight are not always appropriate. Further studies are needed to determine more precise guideline of maximal doses that include various pharmacokinetic components.

• Archives of Reconstructive Microsurgery
• /
• 제19권2호
• /
• pp.97-100
• /
• 2010

Purpose: Epidermolysis bullosa is a rare genetic disease, characterized by the presence of extremely fragile skin and formation of recurrent blister resulting from even a minor mechanical injury. Squamous cell carcinoma (SCC) is recognized as a complication of the chronic scarring associated with dystrophic epidermolysis bullosa (DEB). When a soft tissue defect happens in a patient with epidermolysis bullosa, it is difficult to cover it with a skin graft or a flap. We describe the successful use of a pedicled deep inferior epigastric perforator flap for the reconstruction of SCC associated with DEB in the groin. Methods: A 29-year-old man diagnosed with DEB at birth sustained an ulcer increasing in the right groin for the last 7 months. Under general anesthesia, the mass lesion and lymph nodes were removed and the resulting defect was covered with a pedicled deep inferior epigastric perforator flap. Results: The flap survived completely and his postoperative course was uneventful. Histopathological examination revealed a SCC in the right groin and malignant tumor cells in the removed lymph nodes as well. Additional positron emission tomogram showed a malignant lesion in the ileocecal area with regional lymph node metastasis. The patient was referred to an oncologist for chemotheraphy, but the patient refused to take it. During a 4-month follow-up period, there was no recurrence in the right groin. Conclusion: We suggest that perforator flaps can be considered as a reliable alternative for the reconstruction of soft tissue defects in a patient with DEB.

• Radiation Oncology Journal
• /
• 제21권4호
• /
• pp.261-268
• /
• 2003

목적: 편도암으로 진단받고 근치적 목적의 치료를 시행받은 환자들의 치료성적을 후향적으로 분석하여 그 결과를 보고하고자 하였다. 대상 및 방법: 1995년 1월부터 2000년 12월까지 삼성서울병원에서 편도의 편평상피세포암으로 진단받고 근치적 목적의 치료가 시행된 27례를 대상으로 하였다. 대상환자들에 대한 국소치료법의 결정은 두경부 종양 협진팀에서 합의하여 결정하였으며, 방사선치료를 우선적으로 고려하였던 기준은 (1) 환자측 요인으로 전신마취와 수술의 위험이 큰 경우, (2) 환자의 수술 거부, (3) 근치적 수술절제가 여의치 않거나, (4) 수술 후 기능장애가 클 것으로 예견된 경우 등이었다. 국소치료법으로 수술을 우선적으로 시행하고 수술 후 방사선치료를 선별적으로 추가한 경우가 17명이었고(S$\pm$RT군), 근치적 방사선치료 단독 혹은 동시병용 방사선-항암화학요법을 시행한 경우가 10명이었다(RT$\pm$CT군). 대상 환자들에 대한 추적관찰기간은 3$\~$94 (중앙값 41)개월이었다. 결과: AJCC 병기는 I$\~$II병기가 4명, III병기가 2명, IV병기가 21명이었다. 전체 환자의 5년 무병생존율은 73.3$\%$ 였고, 5$\pm$RT군과 RT$\pm$CT군 각각 70.6$\%$와 77.8$\%$였다. 관찰기간 중 모두 7명에서 재발이 발현하였으며, 이들은 모두 III$\~$IV병기 환자들이었고 치료개시 후 2년 이내에 재발하였다. S$\pm$RT군에서는 국소재발 2명, 영역재발 2명, 원격전이 1명을 포함하여 모두 5명이 재발하였고(조재발률=29.4$\%$), RT$\pm$CT군에서는 국소+영역재발 1명, 원격전이 1명을 포함하여 2명이 재발하였다(조재발률=20$\%$). 전체 환자의 5년 생존율은 77.0$\%$였고, S$\pm$RT군과 RT$\pm$CT군별로는 각각 80.9$\%$와 70.0$\%$였다. 결론: 저자들은 편도암에 대한 국소치료법으로서 수술을 주로 적용한 경우와 방사선치료를 주로 적용한 경우 모두에서 다른 문헌들에서 보고되는 국소제어율, 생존율과 비슷한 수준의 비교적 좋은 치료결과를 얻을 수 있었다. 국소적으로 진행된 편도암에서 방사선치료를 근간으로 하는 치료법은 수술에 의한 기능장애를 피할 수 있는 대안으로 판단된다.

• Applied Microscopy
• /
• 제24권4호
• /
• pp.61-77
• /
• 1994

The calcium-binding proteins (CaBP), parvalbumin (PV) and calbindin-D 28K (calbindin) are particularly abundant and specific in their distribution, and present in different subsets of neurons in many brain regions. Although their physiological roles in the neurons have not been elucidated, they are valuable markers of neuronal subpopulations for anatomical and developmental studies. This study is designed to characterize dorsal lateral geniculate nucleus (dLGN) neurons and axon terminals in terms of differential expression of immunoreactivity (IR) for two well-known CaBPs, PV and calbindin. The experiments were carried out on 6 adult monkeys. Monkeys were perfused under deep Nembutal anesthesia with 2% paraformaldehyde and 0.2% glutaraldehyde in 0.1M phosphate buffer. After removal, the brains were postfixed for 6-8 hr in 2% paraformaldehyde at $4^{\circ}C$ and infiltrated with 30% sucrose at $4^{\circ}C$. Thereafter, they were frozen in dry ice. Serial sections of the thalamus, at $20{\mu}m$, were made in the frontal plane with a sliding microtome. The sections were stained for PV and calbindin with indirect immunocytochemical methods. For electron microscopy, after infiltration with 30% sucrose the blocks of thalamus were serially sectioned at $50{\mu}m$ with a Vibratome in the coronal plane and stained immediately by indirect ABC methods without Triton X-100 in incubation medium. Stained sections were postfixed in 0.2% osmium tetroxide, dehydrated and flat-embedded in Spurr resin. The block was then trimmed to contain only a selected lamina or interlaminar space. The dLGN proper showed strong PV IR in fibers in all laminae and interlaminar zones. Particularly dense staining was noted in layers 1 and 2 that contain many stained fibers from optic tract. Neuronal cell body stained with PV was concentrated only in the laminae. In these laminae staining was moderate in cell bodies of all large and medium-sized neurons, and was strong in cell bodies of some small neurons together with their processes. Calbindin IR was marked in the neuronal cell body and neuropil in the S layers and interlaminar zones whereas moderate in the neuropil throughout the nucleus. Regional difference in distribution of PV and calbindin IR cell is distinct; the former is only in the laminae and the latter in both the S layer and interlaminar space. The CaBP-IR elements were confined to about $10{\mu}m$ in depth of Vibratome section. The IR product for CaBP was mainly associated with synaptic vesicle, pre- and post-synaptic membrane, and outer mitochondrial membrane and along microtubule. PV-IR was noted in various neuronal elements such as neuronal soma, dendrite, RLP, F, PSD and some myelinated or unmyelinated axons, and was not seen in the RSD and glial cells. Only a few neuronal components in dLGN was IR for calbindin and its reaction product was less dense than that of PV, and scattered throughout cytoplasm of soma of some relay neurons, and was also persent in some dendrite, myelinated axons and RLP. The RSD, F, PSD and glial elements were always non-IR for calbindin. Calbindin labelled RLP were presynaptic to unlabeled dendrite or dendritic spine and PSD. Calbindin-labeled dendrite of various sizes were always postsynaptic to unlabeled RSD, RLP or F. From this study it is suggested that dLGN cells of different functional systems and their differential projection to the visual cortex can be distinguished by differential expression of PV and calbindin.

• Journal of Yeungnam Medical Science
• /
• 제10권2호
• /
• pp.451-474
• /
• 1993

전신마취, 부위 또는 국소 마취시, 그리고 향부정맥제로 술중 및 중환자실에서 흔히 쓰이는 lidocaine의 용량과, 국소 마취제로 인한 중추 신경계의 독성을 예방 또는 중단시키기 위해 사용되는 diazepam의 전투여시 이로 인한 심혈관계 변화 및 lidocaine의 혈중농도를 관찰, 측정하여 환자의 관리 및 치료에 도움을 얻고자 본 실험을 하였다. Nitrous oxide, halothane으로 마취된 개에서 근육이완제 사용 후 조절호흡하에서 혈중 이산화탄소를 35-45mmHg로 유지하면서 국소 마취체인 lidocaine의 용량을 100 mcg/kg/min, 200 mcg/kg/min, 300 mcg/kg/min로 각각 30분간 지속적 침제하면서, diazepam 전투여 유무에 따른 심혈 역학치의 변화 및 lidocaine의 혈중농도를 측정하고, 억제된 심혈관계에 $CaCl_2$를 투여하여 회복 정도를 관찰하였던 바 아래와 같은 결과를 얻었다. Lidocaine의 지속적 침제량이 증가됨에 따라 심혈관계의 억제가 심하게 나타났으며 평균 동맥압, 심장지수, 일회 박출지수, 좌심실 박출 작업지수, 우심실 박출 작업지수 등은 감소하였고 (p<0.05), 폐동맥 쐐기압, 중심 정맥압, 전신혈관 저항지수 등은 증가하였으나 (p<0.05), 심박동수, 평균 폐동맥압, 폐혈관 저항지수의 변화는 거의 없었다. Lidocaine 100 mcg/kg/min 지속적 침제시는 diazepam을 투여한 II군에서만 평균 동맥압의 의의있는 감소를 보였으며 (p<0.05), lidocaine의 혈중농도는 diazepam투여하지 않은 I군에서는 $3.97{\pm}0.22$에서 $4.48{\pm}0.36$ mcg/ml 범위였고 II 군에서는 $3.70{\pm}0.32$에서 $4.10{\pm}0.22$ mcg/ml범위였다. Lidocaine 200 mcg/kg/min의 지속적 침제시는 I군에서는 평균 동맥압의 감소, 중심정액압의 증가를 나타내었고 (p<0.05), II 군에서는 심장지수의 감소, 폐동백 쐐기압의 증가를 나타내었으며 (p<0.05), lidocaine의 혈중농도는 I군은 $7.50{\pm}0.66$에서 $7.91{\pm}0.77$ mcg/ml, II군에서는 $7.64{\pm}0.79$에서 $8.23{\pm}1.18$ mcg/ml범위로 증가하였다. Lidocaine 300 mcg/kg/min의 지속적 침제시는 I군에서는 평균동맥압, 일회 박출지수, 좌심실 박출 작업지수의 감소가 있었고 (p<0.05), 폐동맥 쐐기압, 중심 정맥압, 전신혈관 저항지수의 증가를 나타내었다 (p<0.05). II군에서는 심장지수, 일회 박출지수, 좌심실 박출 작업지수의 감소가 있었으며 (p<0.05), 폐동맥 쐐기압, 중심 정맥압, 전신혈관 저항지수의 증가를 나타내었다 (p<0.05). 그러나 심박동수, 폐동맥압의 변화는 거의 관찰할 수 없었다. 또한 이때의 혈중 lidocaine의 농도는 I군에서는 $11.30{\pm}2.11$에서 $11.83{\pm}0.59$ mcg/ml범위 로, II군에서는 $12.95{\pm}0.71$에서 $13.79{\pm}0.82$mcg/ml의 범위로 나타내었다. $CaCl_2$ 투여 후는 억제된 심장지수, 일회 박출지수, 전신혈관 저항지수, 폐혈관 저항지수, 좌심실 박출작업지수 및 우심실 박출 작업지수는 회복시켰으나 (p<0.05), 폐동맥 쐐기압, 중심정맥압 등은 오히려 억제시켰다 (p<0.05). 이상에서 자율신경계에 손상이 없으며 산혈증 및 과탄산증이 없는 개에서는 lidocaine의 높은 혈중 농도치에서도 혈역학에 내성이 있었으며, ljdocaine의 중추신경계 독성의 예방 및 치료 목적으로 사용되는 diazepam의 전투여 시에도 추가적인 심혈관계의 억제가 없음을 알 수 있었다. 그러나 자율신경계 이상이 있거나 자율신경계를 억압할 수 있는 약을 사용할 때 또는 산혈증, 과탄산증 및 저산소증이 동반된 환자에 사용할 때에는 세심한 주의가 요할 것으로 생각된다.